Asthma Right Care Resources | Primary Care Respiratory Society

Asthma Right Care (ARC) Resources

The nine processes to achieve ARC	Practice and Pharmacy Posters
In this article for Primary Care Respiratory Academy, Noel Baxter describes the 9 good care processes developed by a multidisciplinary and integrated respiratory team in Lambeth and Southwark with a novel way to disseminate the measures and show improvement. Download the asthma review MS Excel template described in the article. Download the asthma value pyramid.	PCRS offer two posters available for download and use in practice surgeries and pharmacies. The posters highlight the benefit of regular preventer inhaler therapy and a reduction in reliance on short -acting reliever inhalers. Both posters recommend talking to the practice nurse or pharmacist if patients feel they are reliant on their reliever inhaler more than three times per week of if asthma symptoms are frequent.
ARC Playing Cards	Building Blocks of a Good Asthma Review
A set of playing cards (on slides and downloadable PDF) can be a way to trigger conversations with healthcare teams, and between pharmacists and patients regarding the use of/reliance on SABA inhalers	In this article first published in Primary Care Respiratory Update in 2016 as a poster for primary care and updated for asthma in November 2019 we discuss the building blocks of a good asthma review focusing on: Assessing control to target care Reviewing diagnosis and management Confirmation of diagnosis Previous medical history Patient understanding Checking inhaler technique Discussing and reviewing adherence to therapy Checking smoking status and offering appropriate smoking cessation advice where appropriate Reviewing lifestyle and asthma triggers Reviewing other conconitant conditions Reviewing treatment in line with national guidance Reviewing and discussing asthma action plan Tailoring asthma action plan to meet patient's needs and setting agreed goals Utilising Asthma Right Care tools to assess reliance on short-acting beta-2-agonsts

The nine processes to achieve ARC

Practice and Pharmacy Posters

In this article for Primary Care Respiratory Academy, Noel Baxter describes the 9 good care processes developed by a multidisciplinary and integrated respiratory team in Lambeth and Southwark with a novel way to disseminate the measures and show improvement.

Download the asthma review MS Excel template described in the article.
Download the asthma value pyramid.

PCRS offer two posters available for download and use in practice surgeries and pharmacies. The posters highlight the benefit of regular preventer inhaler therapy and a reduction in reliance on short -acting reliever inhalers. Both posters recommend talking to the practice nurse or pharmacist if patients feel they are reliant on their reliever inhaler more than three times per week of if asthma symptoms are frequent.

ARC Playing Cards

Building Blocks of a Good Asthma Review

A set of playing cards (on slides and downloadable PDF) can be a way to trigger conversations with healthcare teams, and between pharmacists and patients regarding the use of/reliance on SABA inhalers

In this article first published in Primary Care Respiratory Update in 2016 as a poster for primary care and updated for asthma in November 2019 we discuss the building blocks of a good asthma review focusing on:

Assessing control to target care
Reviewing diagnosis and management
Confirmation of diagnosis
Previous medical history
Patient understanding
Checking inhaler technique
Discussing and reviewing adherence to therapy
Checking smoking status and offering appropriate smoking cessation advice where appropriate
Reviewing lifestyle and asthma triggers
Reviewing other conconitant conditions
Reviewing treatment in line with national guidance
Reviewing and discussing asthma action plan
Tailoring asthma action plan to meet patient's needs and setting agreed goals
Utilising Asthma Right Care tools to assess reliance on short-acting beta-2-agonsts

The Asthma Right Care initiative was originated by the IPCRG with funding from AstraZeneca internationally. The adaptation of materials by PCRS for use in the UK has been funded by AstraZeneca UK Limited.